KRAS and BRAF mutations are mutually exclusive in CRC: the shortage of BRAF mutations detected in appendiceal neoplasms with PMP seems to be a consistent consequent high prevalence of KRAS mutations among appendiceal mucinous neoplasms (Tokunaga et al. 2019). This evidence concerns the gene BRAF and appendiceal neoplasm.